Tag: glp_1

• Media Monitor: Cornell Chronicle details new research, podcast season, and faculty contributions to national news

  25 Aug 2026 4:01 p.m. · Source: Cornell Chronicle

  The Cornell Chronicle reports on its 'Research Matters' podcast, films for the Obama Presidential Center, and new genetic research. It also highlights Cornell experts quoted by AXIOS and ABC News.

  Science & TechnologyHealthBusinessMediaMedical ScienceArtificial IntelligenceEmployment and LaborEconomyFilm and TVEducation Cornell ChronicleResearch MattersObama Presidential CenterIntestinal MicrobesUAW-DeereGLP-1

• Media Monitor: Mayim Bialik Reports Severe GLP-1 Side Effects

  5 Jun 2026 8:10 p.m. · Source: USA TODAY

  USA TODAY is reporting that actress Mayim Bialik shared her "horrific" experience with side effects after taking a GLP-1 medication, detailing the adverse reactions she encountered.

  HealthMediaMedical ScienceDigital and Print Publishing Mayim BialikGLP-1Side effectsMedicationCelebrityPharmaceuticalsUSA TODAY

• Media Monitor: Washington Post Reports on New Weight Loss Drug, Congressional Absence, and Fair Performer Withdrawals

  29 May 2026 2:16 p.m. · Source: The Washington Post

  The Washington Post is reporting on Eli Lilly's experimental GLP-1 drug, Rep. Tom Kean Jr.'s absence from Congress, and performer withdrawals from the Great American State Fair.

  HealthPolitics and GovernmentEntertainmentBusinessMedical ScienceGeneral PoliticsCongressSocial IssuesMusic Eli LillyGLP-1Tom Kean Jr.Great American State FairPoliticsWeight LossThe Washington Post

• NIH Researchers Identify Pathway to Enhance GLP-1 Weight Loss Effects

  22 May 2026 7:57 a.m. · Source: National Institutes of Health

  NIH scientists have identified key intracellular signaling pathways in neurons that influence GLP-1 drug semaglutide's weight-loss effects. Modulating these pathways, particularly cAMP levels, could lead to more sustained and effective treatments for obesity.

  HealthScience & TechnologyPolitics and GovernmentMedical ScienceFederal Government NIHGLP-1SemaglutideWeight LosscAMPNIDDKRoflumilastNational Institutes of Health

• GLP-1 Therapy Reduces Heavy Drinking in Patients with Alcohol Use Disorder and Obesity

  12 May 2026 12:57 p.m. · Source: NIH RESEARCH MATTERS

  People with alcohol use disorder and obesity showed reduced heavy drinking when treated with a GLP-1 drug combined with cognitive behavioral therapy, potentially offering a new treatment approach for both conditions.

  HealthScience & TechnologyMedical ScienceSocial Issues GLP-1Alcohol Use DisorderObesityCognitive Behavioral TherapyAddiction TreatmentMedical ResearchPublic HealthNIH RESEARCH MATTERS

• Harvard Researchers Reveal Provocative Cancer Genetics Findings Alongside New Faculty Roles

  7 May 2026 7:01 a.m.

  Harvard University shares new insights on cancer genetics and physical activity, introduces part-time catalyst professorships for industry professionals, and highlights upcoming campus events focusing on environmental design and global disaster management.

  Science & TechnologyHealthPolitics and GovernmentWorldMedical ScienceEnvironmentClimate ChangeEducationAfricaFederal Government Harvard UniversityCancer GeneticsDaniel LiebermanMedical ResearchEnvironmental DesignGLP-1

← Back to latest